AFLAC Incorporated  

(Public, NYSE:AFL)   Watch this stock  
Find more results for afl
-0.29 (-0.44%)
Nov 25 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 65.06 - 65.54
52 week 51.41 - 66.23
Open 65.39
Vol / Avg. 1.11M/2.55M
Mkt cap 27.78B
P/E 11.41
Div/yield 0.41/2.52
EPS 5.71
Shares 426.74M
Beta 1.54
Inst. own 68%
Feb 1, 2016
Q4 2015 Aflac Inc Earnings Release (Estimated) - 4:00PM EST - Add to calendar
Dec 3, 2015
Aflac Inc 2016 Outlook Corporate Call - 9:00AM EST - Add to calendar
Nov 10, 2015
Aflac Inc at Credit Suisse Boston Financials 1x1 Conference
Oct 28, 2015
Q3 2015 Aflac Inc Earnings Call
Oct 27, 2015
Q3 2015 Aflac Inc Earnings Release
Sep 10, 2015
Aflac Inc at PR Newswire and BetterInvesting (NAIC) Investor Conference
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '15) 2014
Net profit margin 10.95% 12.97%
Operating margin 17.98% 21.13%
EBITD margin - 26.37%
Return on average assets 1.95% 2.45%
Return on average equity 13.27% 17.90%
Employees 9,235 -
CDP Score - 87 B


United States - Map
+1-706-3233431 (Phone)
+1-706-3246330 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
About Company - Wikipedia


Aflac Incorporated (Aflac) is a business holding company. The Company is engaged in supplemental health and life insurance, which is marketed and administered through its subsidiary, American Family Life Assurance Company of Columbus (Aflac). Aflac offers insurance policies in Japan and the United States that provide a layer of financial protection against income and asset loss. Aflac's insurance business consists of two segments: Aflac Japan and Aflac U.S. Aflac Japan sells voluntary supplemental insurance products, including cancer plans, medical indemnity plans, medical/sickness riders, care plans, living benefit life plans, ordinary life insurance plans and annuities. Aflac U.S. sells insurance products, including products designed to protect individuals from depletion of assets, such as accident, cancer, critical illness/care, hospital intensive care, hospital indemnity, fixed-benefit dental and vision care plans, and loss-of-income products.

Officers and directors

Daniel P. Amos Chairman of the Board, Chief Executive Officer of the Company and Aflac
Age: 64
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Kriss Cloninger III President, Treasurer, Director
Age: 67
Bio & Compensation  - Reuters
Charles Ditmars Lake II President
Age: 53
Bio & Compensation  - Reuters
Frederick J. Crawford Chief Financial Officer, Executive Vice President
Age: 51
Bio & Compensation  - Reuters
Teresa L. White President - Aflac U.S
Age: 48
Bio & Compensation  - Reuters
Hiroshi Yamauchi President and Chief Operating Officer of Aflac Japan
Age: 63
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Audrey Boone Tillman Esq. Executive Vice President, General Counsel
Age: 50
Bio & Compensation  - Reuters
Kenneth S Janke Jr Executive Vice President, Deputy Chief Financial Officer
Age: 56
Bio & Compensation  - Reuters
Eric M. Kirsch Executive Vice President, Global Chief Investment Officer of Aflac
Age: 54
Bio & Compensation  - Reuters
June P. Howard Senior Vice President, Financial Services, Chief Accounting Officer
Age: 48
Bio & Compensation  - Reuters